
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8421570
[patent_doc_number] => 08278058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-02
[patent_title] => 'Diagnostic composition and kit for renal cell carcinoma'
[patent_app_type] => utility
[patent_app_number] => 12/672498
[patent_app_country] => US
[patent_app_date] => 2008-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 8357
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12672498
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/672498 | Diagnostic composition and kit for renal cell carcinoma | Aug 5, 2008 | Issued |
Array
(
[id] => 8642365
[patent_doc_number] => 08367348
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-05
[patent_title] => 'Upregulation of RACK-1 in melanoma and its use as a marker'
[patent_app_type] => utility
[patent_app_number] => 12/671415
[patent_app_country] => US
[patent_app_date] => 2008-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12788
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671415
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671415 | Upregulation of RACK-1 in melanoma and its use as a marker | Jul 27, 2008 | Issued |
Array
(
[id] => 4529431
[patent_doc_number] => 07923429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-12
[patent_title] => 'Treatment for CD5+ B cell lymphoma'
[patent_app_type] => utility
[patent_app_number] => 12/173719
[patent_app_country] => US
[patent_app_date] => 2008-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 10879
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/923/07923429.pdf
[firstpage_image] =>[orig_patent_app_number] => 12173719
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/173719 | Treatment for CD5+ B cell lymphoma | Jul 14, 2008 | Issued |
Array
(
[id] => 6588780
[patent_doc_number] => 20100130375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'APOLIPOPROTEIN AII ASSAY METHOD FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/452037
[patent_app_country] => US
[patent_app_date] => 2008-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24335
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130375.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452037
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452037 | Apolipoprotein AII assay method for the in vitro diagnosis of colorectal cancer | Jul 9, 2008 | Issued |
Array
(
[id] => 5585407
[patent_doc_number] => 20090104609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'METHOD FOR DISCRIMINATION OF METAPLASIAS FROM NEOPLASTIC OR PRENEOPLASTIC LESIONS'
[patent_app_type] => utility
[patent_app_number] => 12/164934
[patent_app_country] => US
[patent_app_date] => 2008-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5329
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104609.pdf
[firstpage_image] =>[orig_patent_app_number] => 12164934
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/164934 | Method for discrimination of metaplasias from neoplastic or preneoplastic lesions | Jun 29, 2008 | Issued |
Array
(
[id] => 6024341
[patent_doc_number] => 20110052667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING ANGIOGENESIS AND TUMORIGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/666624
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21918
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052667.pdf
[firstpage_image] =>[orig_patent_app_number] => 12666624
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666624 | COMPOSITIONS AND METHODS FOR INHIBITING ANGIOGENESIS AND TUMORIGENESIS | Jun 26, 2008 | Abandoned |
Array
(
[id] => 8043229
[patent_doc_number] => 20120071334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'Methods And Marker Combinations For Screening For Predisposition To Lung Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/667069
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 53878
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071334.pdf
[firstpage_image] =>[orig_patent_app_number] => 12667069
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/667069 | Methods And Marker Combinations For Screening For Predisposition To Lung Cancer | Jun 26, 2008 | Abandoned |
Array
(
[id] => 5928906
[patent_doc_number] => 20110038865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'ANTIBODY- ENDOSTATIN FUSION PROTEIN AND ITS VARIANTS'
[patent_app_type] => utility
[patent_app_number] => 12/665007
[patent_app_country] => US
[patent_app_date] => 2008-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 40362
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20110038865.pdf
[firstpage_image] =>[orig_patent_app_number] => 12665007
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665007 | ANTIBODY- ENDOSTATIN FUSION PROTEIN AND ITS VARIANTS | Jun 25, 2008 | Abandoned |
Array
(
[id] => 5533025
[patent_doc_number] => 20090232813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Four-Jointed Box (FJX1) In Cancer Diagnosis and Treatment'
[patent_app_type] => utility
[patent_app_number] => 12/146167
[patent_app_country] => US
[patent_app_date] => 2008-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 42896
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232813.pdf
[firstpage_image] =>[orig_patent_app_number] => 12146167
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/146167 | Four-jointed box (FJX1) in cancer diagnosis and treatment | Jun 24, 2008 | Issued |
Array
(
[id] => 5310180
[patent_doc_number] => 20090017461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'Diagnosis of Gynecological Neoplasms by Detecting the Levels of Oviduct-Specific Glycoprotein'
[patent_app_type] => utility
[patent_app_number] => 12/144966
[patent_app_country] => US
[patent_app_date] => 2008-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8533
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20090017461.pdf
[firstpage_image] =>[orig_patent_app_number] => 12144966
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/144966 | Diagnosis of Gynecological Neoplasms by Detecting the Levels of Oviduct-Specific Glycoprotein | Jun 23, 2008 | Abandoned |
| 11/883775 | Methods of Predicting Chemotherapy Responsiveness in Breast Cancer Patients | Jun 12, 2008 | Abandoned |
Array
(
[id] => 7686116
[patent_doc_number] => 20100120025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'Compositions and Methods for Prognosis, Diagnosis, Prevention and Treatment of Cancers'
[patent_app_type] => utility
[patent_app_number] => 12/138608
[patent_app_country] => US
[patent_app_date] => 2008-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25056
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120025.pdf
[firstpage_image] =>[orig_patent_app_number] => 12138608
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/138608 | Compositions and Methods for Prognosis, Diagnosis, Prevention and Treatment of Cancers | Jun 12, 2008 | Abandoned |
Array
(
[id] => 8114715
[patent_doc_number] => 08158573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-17
[patent_title] => 'Therapeutic and diagnostic conjugates for use with multispecific antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/138065
[patent_app_country] => US
[patent_app_date] => 2008-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 30404
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/158/08158573.pdf
[firstpage_image] =>[orig_patent_app_number] => 12138065
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/138065 | Therapeutic and diagnostic conjugates for use with multispecific antibodies | Jun 11, 2008 | Issued |
Array
(
[id] => 5526796
[patent_doc_number] => 20090196873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'Methods and compositions for treating diseases targeting CDCP1'
[patent_app_type] => utility
[patent_app_number] => 12/157164
[patent_app_country] => US
[patent_app_date] => 2008-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 36059
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20090196873.pdf
[firstpage_image] =>[orig_patent_app_number] => 12157164
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/157164 | Methods and compositions for treating diseases targeting CDCP1 | Jun 5, 2008 | Abandoned |
Array
(
[id] => 5360505
[patent_doc_number] => 20090035299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'Methods and compositions for treating diseases targeting MABA1'
[patent_app_type] => utility
[patent_app_number] => 12/157162
[patent_app_country] => US
[patent_app_date] => 2008-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 32289
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20090035299.pdf
[firstpage_image] =>[orig_patent_app_number] => 12157162
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/157162 | Methods and compositions for treating diseases targeting MABA1 | Jun 4, 2008 | Abandoned |
Array
(
[id] => 8410462
[patent_doc_number] => 08273858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-25
[patent_title] => 'Polypeptide compounds for inhibiting angiogenesis and tumor growth'
[patent_app_type] => utility
[patent_app_number] => 12/156553
[patent_app_country] => US
[patent_app_date] => 2008-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 109
[patent_figures_cnt] => 134
[patent_no_of_words] => 51364
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12156553
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/156553 | Polypeptide compounds for inhibiting angiogenesis and tumor growth | Jun 1, 2008 | Issued |
Array
(
[id] => 7530245
[patent_doc_number] => 07842467
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-11-30
[patent_title] => 'Breast disease targets and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/156431
[patent_app_country] => US
[patent_app_date] => 2008-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41593
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/842/07842467.pdf
[firstpage_image] =>[orig_patent_app_number] => 12156431
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/156431 | Breast disease targets and uses thereof | May 28, 2008 | Issued |
Array
(
[id] => 5271503
[patent_doc_number] => 20090075279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor'
[patent_app_type] => utility
[patent_app_number] => 12/156180
[patent_app_country] => US
[patent_app_date] => 2008-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 136
[patent_figures_cnt] => 136
[patent_no_of_words] => 76569
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12156180
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/156180 | Compositions and methods for the diagnosis and treatment of tumor | May 28, 2008 | Issued |
Array
(
[id] => 6412858
[patent_doc_number] => 20100166779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Monoclonal Antibodies Against Claudin-18 for Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/601488
[patent_app_country] => US
[patent_app_date] => 2008-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 59
[patent_no_of_words] => 43580
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20100166779.pdf
[firstpage_image] =>[orig_patent_app_number] => 12601488
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/601488 | Monoclonal antibodies against claudin-18 for treatment of cancer | May 26, 2008 | Issued |
Array
(
[id] => 6400805
[patent_doc_number] => 20100179067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-15
[patent_title] => 'SERUM BIOMARKERS FOR THE EARLY DETECTION OF LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/598298
[patent_app_country] => US
[patent_app_date] => 2008-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9685
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20100179067.pdf
[firstpage_image] =>[orig_patent_app_number] => 12598298
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598298 | SERUM BIOMARKERS FOR THE EARLY DETECTION OF LUNG CANCER | May 18, 2008 | Abandoned |